Platelet count predicts prognosis in operable non-small cell lung cancer

Experimental and Therapeutic Medicine

Volumn 5, Issue 5, 2013, Pages 1351-1354

  Yu, Dangfan ^a   Liu, Bingjiang ^a   Zhang, Lizhen ^a   Du, Kaiqi ^a  

^a Zhejiang Provincial Corps Hospital   (China)

Author keywords

Non small cell lung cancer; Platelet counts; Prognosis

Indexed keywords

PLATINUM;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BLOOD CELL COUNT; CANCER PROGNOSIS; CELL DIFFERENTIATION; CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE FREE SURVIVAL; DISTANT METASTASIS; ECHOGRAPHY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; THROMBOCYTE COUNT;

EID: 84876561105     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.1003     Document Type: Article

References (22)

1. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin 62: 10-29, 2012.
2. O'Byrne KJ, Gatzemeier U, Bondarenko I, et al: Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study. Lancet Oncol 12: 795-805, 2011.
3. Douillard JY, Shepherd FA, Hirsh V, et al: Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-cell lung cancer: data from the randomized phase III INTEREST trial. J Clin Oncol 28: 744-752, 2010.
4. Komurcuoglu B, Ulusoy S, Gayaf M, et al: Prognostic value of plasma D-dimer levels in lung carcinoma. Tumori 97: 743-748, 2011.
5. Unsal E, Atalay F, Atikcan S and Yilmaz A: Prognostic significance of hemostatic parameters in patients with lung cancer. Respir Med 98: 93-98, 2004.
6. van Doormaal FF, Raskob GE, Davidson BL, et al: Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials. Thromb Haemost 101: 762-769, 2009.
7. Monreal M, Fernandez-Llamazares J, Piñol M, et al: Platelet count and survival in patients with colorectal cancer-a preliminary study. Thromb Haemost 79: 916-918, 1998.
8. Costantini V, Zacharski LR, Moritz TE and Edwards RL: The platelet count in carcinoma of the lung and colon. Thromb Haemost 64: 501-505, 1990.
9. Shimada H, Oohira G, Okazumi S, et al: Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma. J Am Coll Surg 198: 737-741, 2004.
10. Ikeda M, Furukawa H, Imamura H, et al: Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol 9: 287-291, 2002.
11. Hwang SG, Kim KM, Cheong JH, et al: Impact of pretreatment thrombocytosis on blood-borne metastasis and prognosis of gastric cancer. Eur J Surg Oncol 38: 562-567, 2012.
12. Gonzalez Barcala FJ, Garcia Prim JM, Moldes Rodriguez M, et al: Platelet count: association with prognosis in lung cancer. Med Oncol 27: 357-362, 2010.
13. Gislason T and Nõu E: Sedimentation rate, leucocytes, platelet count and haemoglobin in bronchial carcinoma: an epidemiological study. Eur J Respir Dis 66: 141-146, 1985.
14. Engan T and Hannisdal E: Blood analyses as prognostic factors in primary lung cancer. Acta Oncol 29: 151-154, 1990.
15. Pedersen LM and Milman N: Prognostic significance of thrombocytosis in patients with primary lung cancer. Eur Respir J 9: 1826-1830, 1996.
16. Aoe K, Hiraki A, Ueoka H, et al: Thrombocytosis as a useful prognostic indicator in patients with lung cancer. Respiration 71: 170-173, 2004.
17. Cox G, Walker RA, Andi A, et al: Prognostic significance of platelet and microvessel counts in operable non-small cell lung cancer. Lung Cancer 29: 169-177, 2000.
18. Tomita M, Shimizu T, Hara M, et al: Prognostic impact of thrombocytosis in resectable non-small cell lung cancer. Interact Cardiovasc Thorac Surg 7: 613-615, 2008.
19. Dineen SP, Roland CL, Toombs JE, et al: The acellular fraction of stored platelets promotes tumor cell invasion. J Surg Res 153: 132-137, 2009.
20. Pipili-Synetos E, Papadimitriou E and Maragoudakis ME: Evidence that platelets promote tube formation by endothelial cells on matrigel. Br J Pharmacol 125: 1252-1257, 1998.
21. Placke T, Kopp HG and Salih HR: Modulation of natural killer cell anti-tumor reactivity by platelets. J Innate Immun 3: 374-382, 2011.
22. Nieswandt B, Hafner M, Echtenacher B and Männel DN: Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res 59: 1295-1300, 1999.